Publication | Open Access

Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?

Substance AbusePsychiatryAddictionChronic AdministrationMedicinePsychopharmacologyNeuropharmacologyAddiction MedicinePharmacotherapyNeuroscienceRelapse PotentialPharmacologySocial SciencesOpioid Use Disorder